MKS Instruments (NASDAQ:MKSI) PT Raised to $120.00 at Wells Fargo & Company

MKS Instruments (NASDAQ:MKSIGet Free Report) had its price target upped by analysts at Wells Fargo & Company from $115.00 to $120.00 in a report issued on Tuesday, Benzinga reports. The firm presently has an “equal weight” rating on the scientific and technical instruments company’s stock. Wells Fargo & Company‘s price target would suggest a potential downside of 9.53% from the company’s current price.

Several other equities analysts also recently weighed in on the stock. Needham & Company LLC increased their price target on shares of MKS Instruments from $120.00 to $125.00 and gave the stock a “buy” rating in a report on Thursday, February 8th. StockNews.com upgraded MKS Instruments from a “sell” rating to a “hold” rating in a research report on Thursday, February 15th. KeyCorp upped their price objective on MKS Instruments from $115.00 to $140.00 and gave the stock an “overweight” rating in a research report on Friday, February 9th. TheStreet upgraded MKS Instruments from a “d+” rating to a “c-” rating in a research report on Tuesday, January 23rd. Finally, Benchmark upped their price objective on MKS Instruments from $85.00 to $130.00 and gave the stock a “buy” rating in a research report on Friday, February 9th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $123.00.

Get Our Latest Research Report on MKSI

MKS Instruments Price Performance

Shares of NASDAQ:MKSI opened at $132.64 on Tuesday. MKS Instruments has a twelve month low of $63.44 and a twelve month high of $135.51. The company’s 50 day moving average is $121.69 and its 200 day moving average is $98.58. The company has a current ratio of 3.18, a quick ratio of 2.01 and a debt-to-equity ratio of 1.90. The company has a market cap of $8.89 billion, a PE ratio of -4.81, a price-to-earnings-growth ratio of 4.36 and a beta of 1.67.

MKS Instruments (NASDAQ:MKSIGet Free Report) last issued its quarterly earnings results on Wednesday, February 7th. The scientific and technical instruments company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.28. MKS Instruments had a negative net margin of 50.80% and a positive return on equity of 9.95%. The company had revenue of $893.00 million for the quarter, compared to the consensus estimate of $845.25 million. During the same quarter in the prior year, the company earned $2.00 EPS. MKS Instruments’s quarterly revenue was down 17.7% on a year-over-year basis. On average, sell-side analysts forecast that MKS Instruments will post 4.54 EPS for the current year.

Insider Activity

In other news, Director Gerard G. Colella sold 10,000 shares of the stock in a transaction that occurred on Monday, January 22nd. The stock was sold at an average price of $110.00, for a total transaction of $1,100,000.00. Following the transaction, the director now owns 78,017 shares in the company, valued at approximately $8,581,870. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other MKS Instruments news, Director Gerard G. Colella sold 10,000 shares of the firm’s stock in a transaction on Monday, January 22nd. The stock was sold at an average price of $110.00, for a total value of $1,100,000.00. Following the transaction, the director now owns 78,017 shares in the company, valued at approximately $8,581,870. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Seth H. Bagshaw sold 32,865 shares of the firm’s stock in a transaction on Thursday, February 22nd. The shares were sold at an average price of $123.28, for a total value of $4,051,597.20. Following the completion of the transaction, the chief financial officer now owns 1 shares in the company, valued at approximately $123.28. The disclosure for this sale can be found here. Insiders have sold 60,776 shares of company stock worth $7,326,307 in the last quarter. Corporate insiders own 0.69% of the company’s stock.

Institutional Trading of MKS Instruments

Hedge funds and other institutional investors have recently modified their holdings of the stock. Mendota Financial Group LLC acquired a new stake in shares of MKS Instruments in the 4th quarter worth $27,000. Belpointe Asset Management LLC increased its stake in shares of MKS Instruments by 73.5% in the 1st quarter. Belpointe Asset Management LLC now owns 295 shares of the scientific and technical instruments company’s stock worth $26,000 after acquiring an additional 125 shares during the last quarter. PCA Investment Advisory Services Inc. acquired a new stake in shares of MKS Instruments in the 2nd quarter worth $34,000. GAMMA Investing LLC acquired a new stake in shares of MKS Instruments in the 4th quarter worth $35,000. Finally, Quest Partners LLC acquired a new stake in shares of MKS Instruments in the 4th quarter worth $37,000. 99.79% of the stock is owned by institutional investors and hedge funds.

About MKS Instruments

(Get Free Report)

MKS Instruments, Inc provides foundational technology solutions to semiconductor manufacturing, electronics and packaging, and specialty industrial applications in the United States, Germany, China, South Korea, and internationally. It operates through Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Material Solutions Division (MSD) segments.

Featured Stories

Analyst Recommendations for MKS Instruments (NASDAQ:MKSI)

Receive News & Ratings for MKS Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS Instruments and related companies with MarketBeat.com's FREE daily email newsletter.